Showing 1611-1620 of 4166 results for "".
Set Yourself on the Path to Financial Success
https://modernod.com/topics/business/set-yourself-on-the-path-to-financial-success/38866/Guidelines to help you get started early in your career and keep you on track.Water-Free Ciclosporin-Based Eye Drop for DED Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/water-free-ciclosporin-based-eye-drop-for-ded-approved-in-europe/37052/Novaliq’s water-free ciclosporin-based eye drop for dry eye disease is approved in Europe; the FDA approves first new ophthalmic steroid in over 15 years; and the first slit-lamp mounted rebound tonometer is launched in the US and Europe.Two Partnerships Formed to Advance Glaucoma Treatments
https://modernod.com/podcasts/eyewire-news-the-podcast/two-partnerships-formed-to-advance-glaucoma-treatments/37051/Two collaborations are made to develop and market new glaucoma treatments; Apellis receives feedback from a committee of thee EMA for its geographic atrophy treatment pegcetacoplan; and Topcon receives FDA clearance for OCTA on the company’s Maestro2 fundus camera system.Breaking News From the ESCRS Congress in Barcelona (Part 2 of 2)
https://modernod.com/podcasts/eyewire-news-the-podcast/breaking-news-from-the-escrs-congress-in-barcelona-part-2-of-2/37050/EyewireTV reports on new products and breaking news live from the European Society of Cataract and Refractive Surgeons Congress in Barcelona.Weekly Headlines: Zeiss Lenticule Extraction for Hyperopia
https://modernod.com/podcasts/eyewire-news-the-podcast/eyewire-news-09112024/37049/Zeiss Lenticule Extraction for Hyperopia • Alcon Ngenuity 1.5 • Oculus Pentacam Cornea OCT • Lensar ALLY Adaptive Cataract Treatment System • BVI Serenity IOLs • Topcon TRK-OmniaTreating CCH With RF
https://modernod.com/podcasts/to-the-point/treating-cch-with-rf/36938/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss the benefits of using radio frequency to treat conjunctivochalasis (CCH) with Edward H. Jaccoma, MD, an ophthalmologist who specializes in dry eye and ocular aesthetics. Dr. Jaccoma also offers his insights for patient educatioWeekly Headlines: First Therapy for Acanthamoeba Keratitis Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/eyewire-news-09042024/37048/First Therapy for Acanthamoeba Keratitis Approved in Europe • Oculus Adds Dual Testing Functionality to Easyfield VR • FDA Clears IND Application for Stem Cell Therapy for Primary Photoreceptor DiseasesFive Tips for Creating a More Effective Work Environment
https://modernod.com/topics/business/five-tips-for-creating-a-more-effective-work-environment/38844/Consider incorporating these pearls to improve your delegation and organization needs.New Glaucoma Device Implanted in First Human
https://modernod.com/articles/significant-findings/new-glaucoma-device-implanted-in-first-human/37801/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatLLLT: Not Just for Dry Eye
https://modernod.com/videos/eye-care-insiders/lllt-not-just-for-dry-eye/37347/Joseph J. Allen, OD, FAAO, Dipl ABO, discusses low-level light therapy (LLLT), which has been used in the treatment of dry eye, as a potential use for the management of myopia. He explains how LLLT, aka red light therapy, works to achieve a therapeutic benefit through photobiomodulation, provides a